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For approximately the last 15 years, mitogens have been used to study lymphocyte 
activation.  The  first  identified  mitogens were predominantly plant  lectins such  as 
concanavalin  A  (Con  A),  1 phytohemagglutinin,  and  pokeweed mitogen  (1,  2).  In 
addition, lipopolysaccharide endotoxin (LPS) extracted from the outer membrane of 
Gram-negative bacteria was shown to activate B  lymphocytes (2-4). Subsequently, 
other  components  of the  outer  membranes  of Gram-positive  and  Gram-negative 
bacteria  were  shown  to  be  lymphocyte activators  (5-10),  as  was  purified  protein 
derivative of tuberculin  that  was  recovered from  mycobacteria  (11).  In  addition, 
membrane proteins from mycoplasma and peptidoglycans from the cell walls of yeasts 
were mitogenic for mouse lymphocytes (12-15).  Recently, the list of mitogens  has 
expanded to include the digitalis glycosides (16), low molecular weight chemicals such 
as 2-mercaptoethanol and periodate (17, 18), and the polymers of dextran sulfate and 
polyinosinic-polycytidylic acid (19-21). 
In the late 1970s,  it was reported that influenza virus (H2N2 subtype) and herpes 
simplex virus  (HSV)  types  1 and  2  stimulated mitogenesis in resting nonsensitized 
lymphocytes from mice (22-24). Influenza virus was stimulatory for purified B and T 
cells (22), whereas HSV types 1 and 2 activated B lymphocytes (23, 24). HSV was not 
mitogenic after ultraviolet  (UV)  or heat  inactivation  (23, 24), which  suggests  that 
infectious virus was required for activation, whereas noninfectious influenza virus was 
mitogenic  (22),  which  suggests  that  one or more of the  viral constituents was  the 
mitogenic principle. Because the mitogenic activity of influenza viruses varied with 
the H2 glycoprotein, Butchko et al.  (22)  suggested  that  this viral  glycoprotein was 
responsible for influenza virus mitogenesis. 
Recently we have demonstrated that vesicular stomatitis virus (VSV) was a B cell 
mitogen and  that  UV-inactivated VSV and  defective interfering particles of VSV, 
which do not undergo primary transcription and translation, were mitogenic (25, 26). 
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To  determine  whether  the  VSV  surface  glyeoprotein  (G)  was  responsible  for  the 
mitogenic activity of the virus particle, the G  protein was extracted from the virion 
and tested for its ability to stimulate mitogenesis in lymphocytes. The results reported 
here indicate that the isolated G  protein is a  mitogen and a  polyclonal activator for 
murine B  cells, but neither the isolated G  protein nor the virus particle is mitogenic 
for murine T  cellS. In addition, other viral proteins may also be B  cell mitogens. 
Materials  and  Methods 
Mice.  C3H/HeJ  and  CBA/J  mice were  purchased  from  The Jackson  Laboratory  (Bar 
Harbor, Maine) and maintained in our facility on Purina mouse chow and water ad libitum. 
Female mice between 8 and  16 wk of age were used in all experiments. BALB/c nu/nu female 
mice were obtained from GIBCO Animal Resources Laboratories (Madison, Wis.) and were 
maintained in a sterile laminar flow hood on mouse chow and sterile water ad libitum. These 
mice were used at 7-9 wk of age. 
Lymphocyte Cultures and Mitogenic Assays.  Lymphocytes were cultured as previously described 
(27). Briefly, aseptically removed spleen cells were teased into single cell suspensions in RPMI- 
1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 100 U/ml penicillin 
and  100 #g/ml streptomycin, and washed twice in RPMI-1640. The cells were resuspended, 
counted for viability,  and diluted to 4 ×  108 cells/ml. The cell suspension (0.1 ml) was dispensed 
per well of microtiter plate (Microtest II with lid; Falcon Plastics, Div. of Becton, Dickinson 
& Co., Oxnard, Calif.) and an equal volume of mitogen or medium was added to each well. 
The cultures were incubated in an atmosphere of 10% CO2 in humidified air at 37°C for 48 or 
72  h.  24 h  before harvesting,  1 #Ci of [ H]thymidine (42  Ci/mmol;  New  England Nuclear 
Corp.; Boston, Mass.) was added to each culture. At the end of the culture period, cells were 
harvested  onto  glass  fiber  filters  using  a  multiple  automated  sample  harvester  (Brandei, 
Gaithersburg, Md.)  and  [3H]thymidine incorporation was determined by liquid scintillation 
counting. 
Nylon Wool Separation of Spleen Cells.  Purified T lymphocytes were recovered from nylon wool 
by the method of Hodes et al. (28).  Briefly, 1.2 g sterile nylon wool columns were incubated at 
37°C  for 1 h  with RPMI-1640 plus  10% fetal calf serum (FCS) in a  humidified atmosphere. 
After this preincubation, 300 ×  106 cells in 4 ml of RPMI-FCS were added to the column and 
allowed to flow into the nylon wool; at this time, an additional 2 ml of RPMI-FCS was added 
to the column. The column and cells were incubated for 45 min at 37°C in humidified air and 
10% CO2. After incubation, nonadherent T  cells were removed by adding RPMI-FCS to the 
column and  collecting  15  ml of effluent  (flow rate,  1 ml/2  rain).  The column  was rapidly 
washed with  100 ml RPMI-FCS and this wash was discarded. Nylon wool adherent cells (B 
enriched) were removed by compressing the nylon wool with the syringe plunger to express the 
remaining medium. The nylon wool was removed and teased with sterile forceps, resaturated 
with RPMI-FCS and compressed again, and a  total of 50 ml was collected in 4-5 cycles of 
compression. 
Polyclonal Activation (PCA).  Mouse spleen cell suspensions were prepared at a concentration 
of 10 ×  106 cells/ml.  1 ml of the suspensions was incubated in 35-mm plastic petri dishes at 
37°C in an atmosphere of 83% N2, 10% CO2, and 7% 02 with or without activators as described 
by Nilsson et al. (29).  Antibody-forming cells were identified by a  modification of the Jerne 
hemolytic plaque assay using trinitrophenyl (TNP)-eonjugated sheep erythroeytes (SRBC; 29). 
TNP-SRBC were prepared by the method of Rittenberg and Pratt (30). 
Mitogens.  Salmonella typhosa LPS was prepared by the phenol-water method of Westphal et 
al. (31) and contained <1% protein. Con A was purchased from Sigma Chemical Co. (St. Louis, 
Mo.). 
Cells.  Monolayers of the BHK-21F line of Syrian hamster kidney cells and the MDBK line 
of bovine kidney cells were grown in Falcon tissue culture flasks (75  mm  2)  or plastic tissue 
cultures dishes (100  ×  20  mm)  in Dulbeceo's medium supplemented with  10%  fetal bovine 
serum (32). 
Virus.  Stocks of the Indiana serotype of VSV were initiated from single plaques in BHK- GOODMAN-SNITKOFF, MANNINO, AND McSHARRY  1491 
21F cells, grown in stationary cultures of MDBK cells and assayed on BHK-21F cell monolayers 
as previously described (33). 
Virus Propagation.  VSV  was  grown  in  confluent  monolayers of BHK-21F  cells in  tissue 
culture plates at a multiplicity of infection of 0.05-0.1  plaque-forming U/cell and purified as 
previously described (25).  The purity of the viral preparations was determined by polyacryl- 
amide gel electrophoresis (PAGE) followed by Coomassie Blue staining. Only preparations that 
showed no contaminating proteins were used for mitogen assays. 
Preparation of Purified G and  Triton-insoluble Pellet (TP).  The  procedure for isolating the G 
protein from VSV has been previously described (34).  Briefly, purified VSV (~ 1 mg/ml) was 
diluted 1:5 in 2%  (vol/vol) Triton X-100 (Sigma Chemical Co.) in 0.01  M  Tris, pH 8.0.  The 
solution was mixed gently at room temperature for 45 rain. Insoluble material was removed by 
centrifugation at 30,000 rpm for 1 h  at 4°C in an SW50.1 rotor (Beckman Instruments, Inc., 
Paio Alto, Calif.). The supernate was decanted into 10 vol of ice-cold butanol, and G  protein 
was precipitated in the cold for 0.5 h and recovered by centrifugation at 1,000 rpm for 15 min 
at 4°C. The pelleted G was washed with ice-cold acetone, recovered by low speed centrifugation, 
dried under nitrogen, and resuspended in phosphate-buffered saline (PBS) by sonifieation for 
two  15-s intervals at 30 W  on a  Bronson sonifier (Heat Systems-Ultrasonics, Inc., Plainview, 
N.  Y.).  Purity  of preparations  was  determined  by  Coomassie  Blue-stained  PAGE.  Only 
preparations that had no other proteins present were used for these assays. The Triton-insoluble 
material was washed repeatedly in 5-10 ml PBS and pelleted by centrifugation at 30,000 rpm 
for 1 h at 4°C in an SW50.1 rotor. Its polypeptide composition was determined by PAGE. 
Protease Digestion of VSV.  The glycoprotein of  VSV was enzymatically removed as previously 
described (35). In brief, purified virus was resuspended in 0.1 M Tris (pH 7.2) to a concentration 
of between  1 and 2 mg/ml. One part of Streptomyces griseus protease type VI (Sigma Chemical 
Co.) at a  concentration of 1 mg/ml in Tris buffer was added to nine parts virus. The virus- 
enzyme mixture was incubated at 37°C  for  1.5 h  and then repurified on potassium tartrate 
gradients. Control preparations were treated as described, but no enzyme was added. 
Preparation of Reconstituted G Protein-Lipid Vesicles.  VSV  glycolipids, phospholipids, and  G 
protein were extracted with the nonionic detergent octyl-fl-D-glucoside (Sigma Chemical Co.) 
as previously described (36, 37). Briefly, a pellet of VSV was suspended in 10 mM phosphate 
buffer, pH 8.0, containing 50 mM octyl-fl-D-glucoside  to a final concentration of 2.5 mg viral 
protein/ml. The suspension was vortexed for 30 min at room temperature to disperse clumps, 
followed by an additional incubation for 30 min at room temperature. Insoluble material was 
removed by centrifugation at 40,000 rpm for 40 rain at  15°C, and the supernate was used for 
the preparation of reconstituted vesicles. Vesicles with a high protein:lipid ratio were prepared 
by dialysis of the octyl-fl-D-glucoside  supernate against 2 ×  100 vol of Dulbeeco's PBS. Low- 
protein  lipid  vesicles were  prepared  by  adding  an  additional  0.4  mg  lipid  consisting of 
cholesterol, phosphatidylethanolamine, and phosphatidylcholine (1.6:1.2:1 ; Avanti Biochemi- 
cals, Inc., Birmingham, Ala.) per mg viral protein to the octyl-fl-D-glucoside  supernate of the 
virus. The solution was vortexed to dissolve the lipid and then dialyzed as described above. 
Reconstituted vesicles were removed from the dialysis tubing and tested for mitogenicity. 
Protein Determination.  Protein was determined by the method of Lowry et al. (38). 
Results 
Mitogenic Activity of the G Protein.  The ability of the isolated G  protein to stimulate 
mitogenesis was tested in CBA/J  mouse splenocytes. The results presented in Fig.  1 
show that the VSV glyeoprotein is mitogenie. After 48 h  incubation of the G  protein 
with spleen cells, the optimal stimulatory concentration of the G  protein is between 
5  and  10/~g/well;  higher concentrations of G  protein are inhibitory. Both VSV and 
PBS-washed  TP  were  also  able  to  induce  mitogenesis  in  these  cells.  However,  the 
mitogenic activity of the isolated G  protein is at least two times greater than that of 
either VSV or TP. Because the G  protein represents between 20 and 30% of the total 
protein present  in VSV  (39),  25-50 #g of virus contains between  5  and  15 #g of G 
protein. Although there was as much or more G  present in VSV as in the purified G 1492  VESICULAR STOMATITIS VIRUS GLYCOPROTEIN IS A MITOGEN 
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preparation, maximal stimulation  by VSV is <50%  that of isolated G  protein, and 
increasing the concentration of VSV did not enhance stimulation. This result shows 
that  the  isolated  G  protein  is  a  more  efficient  mitogen  than  the  virus  particles. 
Furthermore, the amount of [SH]thymidine incorporated in the presence of an optimal 
concentration  of G  protein  (5-10  /~g) was  very  similar  to  that  incorporated  by 
stimulation with 50 btg LPS, a known B cell mitogen (see Fig. 3). 
Mitogenic Activity  of the G Protein in C3H/HeJ Mouse Spleen Cells.  We have reported 
previously that VSV mitogenesis is not due to contamination with  LPS by demon- 
strating that VSV is mitogenic in spleen cells isolated from C3H/HeJ mice, which are 
low responders to mitogenesis by LPS  (25,  26).  To demonstrate that  the mitogenic 
activity illustrated in Fig.  1 is due to G protein and not LPS, we compared the ability 
of the  G  protein,  TP,  and  VSV  to  stimulate  incorporation  of [3H]thymidine  into 
spleen cells isolated from C3H/HeJ and C:BA/J mice. The data presented in Fig.  2 
demonstrate  that  the G  protein, VSV,  and  the TP  stimulate  mitogenesis in  spleen GOODMAN-SNITKOFF,  MANNINO,  AND  McSHARRY  1493 
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FIc.  2.  Response of CBA/J and C3H/HeJ  to G  protein, TP, and BHK-VSV 48 h  after culture 
initiation, 
cells isolated from both strains of mice. PAGE of these preparations showed only viral 
proteins, indicating the absence of any detectable contaminating protein. On the basis 
of these experiments, we conclude that the G  protein is a mitogen for murine spleen 
cells. 
Mitogenic Activity of the G Protein in Lipid Vesicles.  To determine whether the isolated 
G  protein  could be  mitogenic when  it  was  incorporated into a  membrane,  the G 
protein  and  viral  lipids  were  extracted  from  virus  with  octyl-fl-o-glucoside, the 
insoluble  material  was  removed by  centrifugation,  and  vesicles containing  the  G 
protein  and  viral  lipids  were  formed  while  removing  the  octyl-fl-D-glucoside by 
dialysis. Various concentrations of vesicles were incubated with spleen cells isolated 
from CBA/J mice and mitogenesis was determined at 48 h. The data in Table I show 
that the G  protein in lipid vesicles reconstituted with viral lipids was as mitogenic as 
VSV, whereas the G  protein in lipid vesicles containing twice as much lipid as those 
consisting of viral lipids alone, is considerably less mitogenie. Lipid vesicles containing 
only cholesterol, phosphatidylethanolamine, and  phosphatidylcholine are not mito- 1494  VESICULAR  STOMATITIS  VIRUS  GLYCOPROTEIN  IS A MITOGEN 
TABLE  I 
Mitogenic Activity of the G Protein in Lipid Vesicles 
Mitogen  #g/ml  [ ~lTh,~  ~d~  t3  j__:m.~.ne incorporation 4- 
SE* 
None 
VSV 
Reconstituted VSV 
Reconstituted VSV + lipid 
Lipid$ 
--  2,683 4- 181 
1  4,028 4- 384 
5  12,133 4- 372 
10  16,792 ± 338 
25  13,719 ±  1,262 
0.8  5,783 ±  178 
4  11,863 ±  1,223 
8  22,610 ±  1,015 
21  19,204 ±  1,637 
0.8  4,807 ± 359 
4  4,742 ± 278 
8  5,274 ± 549 
21  1,107 4- 309 
1.25  2,407 ± 284 
1.5  2,658 4- 44 
2.5  1,667 ±  143 
* SE, standard error of the mean of triplicate samples. 
$ Dilutions of lipid vesicle  without protein comparable to the dilution of vesicles containing G protein. 
TAnLE II 
Activation of B Lymphocytes by G Protein 
Mitogen  #g/well 
[SH]Thymidine  incorporation (cpm) + SE* 
CBA/J spleen cells  BALB/c nu/nu spleen cells 
None  2,597 4- 231  3,194 ± 301 
G  5  87,947 4- 1,770  61,885 4- 5,889 
10  120,286 4- 9,845  116,153 4- 8,889 
VSV  25  31,425 ± 2,132  26,190 4- 3,663 
TP  25  30,196 4- 2,416  27,169 4- 2,169 
LPS  50  95,183 ± 5,900  89,574 4- 6,588 
Con A  0.125  133,835 4- 6,642  1,450 4- 239 
* See legend to Table I. 
genic, and at higher concentrations may inhibit mitogenesis because the amount of 
[3H]thymidine incorporated in the presence of these vesicles is less than in the absence 
of mitogen. These results show that the G  protein is mitogenic when it is found in a 
proper  configuration  in  a  lipid  bilayer  and  that  the  amount  of  stimulation  is 
dependent on the spacing of the G  protein on the surface of the lipid vesicles. Thus, 
both the G  protein isolated by Triton extraction and used in an aggregated form, and 
the  G  protein isolated by octyl-fl-D-glucoside extraction and reconstituted into the 
bilayer of lipid vesicles, are mitogenic for murine spleen cells. 
G  Protein Is a  B  Cell Mitogen.  We have previously demonstrated that VSV is a  T 
cell-independent, B cell mitogen (25). To determine whether the G  protein is also a 
B  cell mitogen, Triton-extracted G  protein was incubated with splenocytes isolated 
from  CBA/J  or congenitally athymic BALB/c nu/nu  mice. The  data  presented  in 
Table II show that the G  protein is equally stimulatory to spleen cells isolated from 
both strains of mice. In addition, the data show that VSV and TP are also T  cell- GOODMAN-SNITKOFF, MANNINO, AND McSHARRY  1495 
independent,  B  cell  mitogens  because  they  were  mitogenic  in  both  spleen  cell 
preparations. LPS, a recognized T  cell-independent, B cell mitogen (2, 3), stimulates 
spleen cells from both strains of mice. However, Con A, a T  cell mitogen (1,  2), was 
mitogenic in the CBA/J mouse spleen cells but not active in the BALB/c nu/nu cells, 
indicating  that  there are no functional  T  cells in the nude  spleen cell preparation. 
The results of these experiments demonstrate that the G protein is a T  cell-independ- 
ent, B cell mitogen. 
G Protein and VSVAre Polyclonal Activators.  Because most nonspecific B cell mitogens 
are also polyclonal activators (20), the ability of G protein, VSV, and TP to stimulate 
nonspecific  antibody  production  was  examined.  As  shown  in  Table  III, VSV,  G 
protein,  and TP  all  activated lymphocytes to  make antibody against  TNP-SRBC, 
although not as efficiently as LPS. In contrast to the greatly enhanced proliferation 
induced by isolated G protein as compared with the intact virion, both G protein and 
VSV stimulated similar numbers of plaque-forming cells. The ability of TP to induce 
PCA is considerably decreased compared with either G  protein or VSV, suggesting 
that G  protein is required for PCA. 
G  Protein and  VSV Do  Not  Activate  T  Cells.  Preliminary  results  with  VSV  had 
indicated  that  it  did  not  stimulate  mitogenesis  in  T  lymphocytes  (G.  Goodman- 
Snitkoff, unpublished observations). Because others have demonstrated the ability of 
VSV to replicate in a small percentage of the T  cell population after being activated 
by Con A  (40-42), the possibility existed that VSV was activating these cells and then 
replicating in them, resulting in cell death before the time of our mitogenesis assay. 
To test the possibility that VSV or an active moiety of the virion was able to stimulate 
T  lymphocytes,  normal  spleen  cells  were  separated  on  nylon  wool  columns  into 
nonadherent  (T enriched) and adherent (B enriched) cell populations and assayed for 
their ability to  be stimulated  by TP,  VSV,  or G  protein.  As shown  in  Fig.  3,  the 
untreated spleen cells responded to all the mitogens assayed. The response of unsep- 
arated mouse spleen cells to G  protein, TP, and VSV peaked at 48 h  and was lower 
at  72 h. The response to LPS was the same at 48 and 72 h; and the response to Con 
A was evident at 48 h and increased at 72 h. At 48 h, the unseparated cells responded 
to G  protein  and  to  LPS essentially equally;  however,  the  mitogenic activity of G 
protein was ~4 times greater than that of VSV or TP. Nonadherent T-enriched cells 
TABLE III 
Stimulation of Plaque-forming Cells by G Protein 
Anti-TNP-SRBC/10  6 
Mitogen  #g/ml  cells* 
G  10  82 
25  77 
50  70 
VSV  25  7O 
50  84 
I00  I01 
TP  25  7 
50  41 
100  48 
LPS  100  186 
* This is a representative experiment of four; background levels  were <5 PFC. 1496  VESICULAR STOMATITIS  VIRUS GLYCOPROTEIN  IS  A  MITOGEN 
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FIG.  3.  The response of nylon-wool  separated spleen cells to different mitogens at 48 and 72  h. 
Abbreviations as in Fig, 2. 
were unresponsive to LPS, the G protein, VSV, or TP at either time, suggesting that 
these are not T  cell mitogens, T-enriched cells were stimulated by Con A at both 48 
and  72 h, and their response to this mitogen was greater than that  of unseparated 
cells. The response of adherent, B-enriched lymphocytes to VSV, isolated G  protein, 
TP, and LPS is enhanced compared with that of untreated ceils, which suggests that 
G protein, TP, and VSV are B lymphocyte activators. The results of these experiments 
show  that  the  G  protein,  TP,  and  VSV  are  not  T  cell  mitogens,  but  are  B  cell 
mitogens as shown before in Table II. 
TP Has Mitogenic  Activity.  The data presented in  this  paper have demonstrated 
that  the  VSV  G  protein  is  a  mitogen  for murine  spleen  cells.  In  all  the  data  we 
presented, TP, which contains the viral membrane (M) protein, the ribonucleoprotein 
(RNP) complex containing large protein (L), nueleocapsid protein (N), nonstructural 
protein (NS), and RNA, very small amounts of G protein (<5%), and no lipid, is also GOODMAN-SNITKOFF, MANNINO, AND McSHARRY  1497 
mitogenic. These results suggest that there is more than one mitogen in VSV. Possibly, 
the membrane or nucleocapsid proteins or both are mitogens. Further evidence that 
there are mitogens in VSV other than G protein comes from mitogenesis experiments 
involving protease-treated VSV.  On  the basis of PAGE,  these particles contain  no 
detectable G  protein but have the hydrophobic tail of the G  protein and all other 
viral proteins  (M,  L, N,  NS)  and  lipid.  The data in Table IV show that  protease- 
treated VSV  is  mitogenic in  CBA/J  spleen cells;  however, it  is  about  one-half as 
mitogenic as  virions, which  suggests  that  half of the  mitogenie activity has  been 
removed. The protease itself is not mitogenic. Taken together, these results suggest 
that some component(s) of the virion, in addition to the G  protein, is mitogenie for 
murine spleen cells. 
Discussion 
The data presented here demonstrate that VSV, TP, and purified G protein are T 
cell-independent, B cell mitogens, but do not activate nylon wool nonadherent T cells. 
In  addition, VSV  and  tlae  isolated G  protein are polyclonal activators for murine 
spleen cells. 
The isolated G protein is highly stimulatory for mouse spleen cells. At the optimal 
concentration  (5-10  #g/well),  the  G  protein  stimulates  as  much  [3H]thymidine 
incorporation as does an optimal concentration of LPS (25-50 #g/well)  and is 2-3 
times as active as either VSV or TP. Lipid vesicles consisting of the G  protein and 
viral lipids isolated using oetyl-/3-D-glueoside were also stimulatory. The purification 
technique used for the isolation of the G protein yields a highly aggregated preparation 
of G  protein, which is  the most stimulatory preparation of G  protein. Virions and 
lipid vesicles composed of viral lipids and G protein are less mitogenic than aggregated 
G protein. Lipid vesicles with a low protein/lipid ratio are less mitogenic than viruses 
and lipid vesicles with a  high protein/lipid ratio. This proportionality of activity is 
also seen when haptenated liposomal membranes are used to study in vivo or in vitro 
immunogenicity (43, 44). It has been found that liposomes that contain <2% hapten 
are not immunogenic and that a threshold level of 2.5% hapten was required for any 
significant response and an optimal response required a  minimum of 5-10% hapten 
TABLE IV 
Mitogenic Activity of Protease-treated VSV 
* See legend to Table I. 
None  --  2,683 ±  181 
VSV  1  2,727 ± 234 
5  8,711 ± 1,093 
10  14,957 :t: 299 
25  21,212 ± 2,215 
Protease°treated VSV  1  3,994 ± 91 
5  6,881 :t: 181 
10  7,601 ± 245 
20  11,427 ±  1,028 
Protease  0.01  1,528 ±  186 
0.05  3,336 ± 242 
0.1  1,628 ±  15 
Mitogen  #g/weU  |  Fl|Thv  ;dl  t3  j_..~m._.ne incorp- 
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liposome. These data correlate well with what we have shown regarding the mitogen- 
icity  of G  protein,  the  aggregated  material  being  the  most  stimulatory,  and  the 
activity decreasing as the G  protein:lipid ratio decreases. These results suggest that 
the purified G  protein is more mitogenic than G  protein in association with mem- 
branes,  possibly because it  is  aggregated.  It  is  possible  that  aggregated  G  protein 
presents more mitogen to the cell surface than the G protein in virus or lipid vesicles. 
Alternatively, different portions of the G protein are presented to the cell surface with 
aggregated G protein than with G protein in its native configuration. Although these 
possibilities are unresolved, it is clear that the G  protein, either as an aggregation of 
purified glycoproteins or in lipid vesicles consisting of viral lipids and G  protein, is 
mitogenic for murine spleen cells. 
On the basis of the data presented here, it is unlikely that the observed mitogenesis 
is due to a contaminant in the preparation. The data supporting this conclusion are 
as follows. Coomassie Blue-stained gels of G  protein contain no resolvable proteins 
other than G, whereas those of the intact virion or TP contain only the appropriate 
viral proteins. Activation of C3H/HeJ lymphocytes by G protein or VSV is equal to 
that  seen in CBA/J  splenocytes; stimulation of C3H/HeJ spleen ceils by naturally 
occurring endotoxin  (LPS)  is  generally lower than  the  activation  seen  in  CBA/J 
lymphocytes (6).  Because endotoxin is a  complex of 8-10% protein and  -90% LPS 
(6), one would expect that any endotoxin protein present in these preparations would 
be resolved on the stained gels. Additionally, G protein stimulates as much mitogenesis 
as  does  LPS,  but  at  an  optimal  concentration  1/5  of that  required  for maximal 
activation by LPS. The other probable contaminant of these preparations is myco- 
plasma.  Mycoplasma proteins have been found to be mitogenic for lymphocytes at 
concentrations equal to or greater than those required for activation by G protein (12, 
13).  Again,  as with endotoxin, if the observed stimulation was due to mycoplasma 
mitogens, proteins other than those of VSV or the purified G  would be resolved by 
PAGE. Furthermore, the response of lymphocytes to mycoplasma mitogens is optimal 
at  72 h  (12,  13), whereas the response to G  protein or VSV peaks at 48 h. It is our 
conclusion, therefore, that G protein, VSV, and TP are responsible for the stimulation 
described here. 
It is interesting that G, which is significantly more mitogenic than VSV, activates 
essentially the same number of plaque-forming cells. Also, TP is much less stimulatory 
in this system than in the induction of mitogenesis when compared with VSV. This 
lack of correlation between mitogenesis and PCA has been demonstrated with other 
B cell mitogens, such as dextran sulfate (19, 20) and lantoside C  (16), which stimulate 
good  mitogenesis  but  poor  PCA  when  compared  with  LPS.  VSV  contains  these 
different activities in the intact virion, but the disruption of the virus results in the 
separation  of the activities into a  strong mitogen and  good PCA  (G), and  a  good 
mitogen  and  weak  PCA  (TP).  The  reason  for  the  lack  of correlation  between 
mitogenesis and PCA by G  protein requires additional investigation. Whether this is 
due  to  disruption  of the  lipid  membrane,  resulting  in  loss  of ability  to  stimulate 
plaque-forming cells,  or  simply  to  the  subset  of B  lymphocytes being  stimulated, 
remains to be studied. The questions of what the active portion of TP is, and whether 
or not the mitogenic and PCA signals are on the same or different components, needs 
to be addressed. 
It  has  been  demonstrated  that  VSV  is  unable  to  stimulate  mitogenesis  in  T GOODMAN-SNITKOFF, MANNINO, AND MeSHARRY  1499 
lymphocytes. One possible explanation was that VSV was activating these cells and 
then multiplying in them, because Bloom et al.  (40,  41)  had shown that VSV was 
able to replicate in mitogenized T lymphocytes, and more recently, data from Minato 
and Katsura (42)  has demonstrated that it  is the nylon wool-adherent T  cell that 
supports the replication of  VSV and not the nonadherent T cell. Because nonadherent 
T  lymphocytes do  not  incorporate  [SH]thymidine in  the presence  of VSV,  the G 
protein, or TP,  we conclude that  this virus  is  not  mitogenic for T  cells. Whether 
purified virion or viral components can stimulate any activity in the cellular arm of 
the immune response, such as interferon production, requires further investigation. 
TP, which contains the viral M  protein, the RNP consisting of proteins L, N, NS, 
and RNA, and a small amount of residual G protein (<5%), but no lipid, is mitogenic 
for  murine  spleen  cells.  Its  mitogenic  activity  is  considerably  less  than  that  of 
aggregated G protein, but is similar to that of virions and lipid vesicles containing G 
protein. Because TP contains only traces of G protein, the mitogenic activity must be 
attributed to some other component of the virion. Additional evidence to suggest that 
subvirus particles lacking the complete G  protein ~are mitogenic is derived from the 
studies  that  demonstrated  the  mitogenic activity of protease-treated  VSV.  These 
particles lack detectable G  protein, but retain the hydrophobic tail of the G protein 
and contain the M protein and the RNP complex. These particles are approximately 
half as active as whole virions in mitogenic assays. In this case, the mitogenic activity 
could be due to the hydrophobic tail of G  protein or some lipid or protein of the 
subvirus particle. These results suggest that there are additional mitogens in VSV. 
Because TP does not contain lipid and retains mitogenic activity, lipids are probably 
not the mitogens. The M  and N proteins are the major proteins that remain in these 
subparticles.  These  will  be  isolated  and  tested  for  mitogenic  activity  in  murine 
splenocytes. 
Although the role of the glycoprotein in stimulating nonspecific mitogenesis was 
suggested by the work of Butchko et al. (22) with influenza virus, the work reported 
here is the first time, to our knowledge, that a purified viral protein has been shown 
to activate murine lymphocytes. 
Summary 
The glycoprotein (G protein) of VSV was purified from the intact virion by Triton 
X-100 extraction. The isolated G protein has been shown to be a T  cell-independent, 
B  lymphocyte mitogen and polyclonal activator. Neither G  protein  nor the intact 
virion are stimulatory for murine T lymphocytes. The greater the density of G protein 
in lipid vesicles  or the degree of aggregation of isolated G  protein, the more highly 
stimulatory it is for murine splenocytes. As G protein is spread out in artificial vesicles, 
it  becomes  less  mitogenic.  It  is  probable  that  other  viral  components  are  also 
stimulatory since the Triton-insoluble pellet and VSV from which the G protein has 
been enzymatically removed retain mitogenic activity. To our knowledge, this is the 
first  time  a  purified viral component  has been  demonstrated to be  a  lymphocyte 
mitogen. 
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